Marinus Pharmaceuticals
MRNS
#9781
Rank
A$48.13 M
Marketcap
$0.87
Share price
0.46%
Change (1 day)
-93.92%
Change (1 year)

Earnings for Marinus Pharmaceuticals (MRNS)

Earnings in 2024 (TTM): -A$0.21 Billion

According to Marinus Pharmaceuticals's latest financial reports the company's current earnings are A$31.46 Million. In 2023 the company made an earning of -A$0.24 Billion a decrease over its 2022 earnings that were of -A$26.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marinus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.21 Billion-9.09%
2023 -A$0.24 Billion770.17%
2022 -A$26.45 Million-83.37%
2021 -A$0.16 Billion46.39%
2020 -A$0.11 Billion24.67%
2019 -A$87.13 Million47.37%
2018 -A$59.12 Million94.33%
2017 -A$30.43 Million-34.02%
2016 -A$46.12 Million15.24%
2015 -A$40.02 Million129.47%
2014 -A$17.44 Million105.55%
2013 -A$8.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$16.56 Million-92.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$57.4 M-125.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.86 Billion 1,602.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.11 B-151.59%๐Ÿ‡บ๐Ÿ‡ธ USA